Screener
Myriad Genetics MYGN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
FAQ
- What is Myriad Genetics's enterprise value?
- Myriad Genetics (MYGN) reported enterprise value of $506.29M in Q1 2026.
- How has Myriad Genetics's enterprise value changed year-over-year?
- Myriad Genetics's enterprise value decreased by 41.6% year-over-year, from $866.51M to $506.29M.
- What is the long-term trend for Myriad Genetics's enterprise value?
- Over 5 years (2020 to 2025), Myriad Genetics's enterprise value has grown at a -18.4% compound annual growth rate (CAGR), from $1.75B to $631.76M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Myriad Genetics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude